EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:EBR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
EBR Systems, Inc., a pioneer in wireless cardiac pacing technology, has successfully completed its Day-100 PMA meeting with the FDA, keeping its timeline for FDA approval and U.S. commercial launch on track for 2025. This milestone is part of the regulatory process for their innovative WiSE® CRT System, which is designed to improve heart failure treatment by eliminating external pacing leads. The company’s breakthrough device designation allows for prioritized review and interactive communication with the FDA, streamlining the path to market.
For further insights into AU:EBR stock, check out TipRanks’ Stock Analysis page.